Related Experiment Video

Updated: Jul 18, 2026

Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation
17:28

Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation

Published on: June 17, 2015

The detoxification enzyme systems

D J Liska1

  • 1HealthComm International, Inc. P.O. Box 1729, Gig Harbor, WA 98335, USA. deann@healthcomm.com

Alternative Medicine Review : a Journal of Clinical Therapeutic
|June 19, 1998
PubMed

Insights

The human body uses complex enzyme systems to detoxify harmful xenobiotics, but individual variability influenced by genetics and lifestyle can impair this process, potentially linking to chronic diseases.

Area of Science:

  • Biochemistry
  • Toxicology
  • Human Physiology

Background:

  • The human body encounters numerous xenobiotics (environmental toxins, pharmaceuticals, food components) throughout life.
  • Complex enzymatic mechanisms have evolved for xenobiotic detoxification, but these systems display significant individual variability.
  • Impaired detoxification is increasingly associated with chronic diseases such as cancer, Parkinson's disease, fibromyalgia, and chronic fatigue/immune dysfunction syndrome.

Purpose of the Study:

  • To review the multifaceted xenobiotic detoxification enzyme systems in the human body.
  • To explore the regulatory mechanisms governing these hepatic detoxification pathways.
  • To examine the influence of dietary, lifestyle, and genetic factors on detoxification enzyme activity.

Main Methods:

  • Review of scientific literature on xenobiotic metabolism and detoxification pathways.
  • Analysis of regulatory mechanisms of hepatic detoxification enzymes.
  • Compilation of data on factors affecting enzyme activity and their association with chronic diseases.

Main Results:

  • Detoxification mechanisms are highly variable due to genetic, environmental, and lifestyle factors.
  • Efficient xenobiotic detoxification and removal are crucial for preventing or managing chronic disease processes.
  • Laboratory tests are available to assess the functioning of these vital detoxification systems.

Conclusions:

  • Understanding individual detoxification capacity is key to addressing xenobiotic-related health risks.
  • Modulating dietary, lifestyle, and environmental factors can support detoxification pathways.
  • Further research into genetic influences and personalized detoxification strategies is warranted.

More Related Videos

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures10:44

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures

Published on: March 28, 2017

Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling09:33

Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling

Published on: March 20, 2018

Related Concept Videos

Peroxisomes01:30

Peroxisomes

Peroxisomes and mitochondria are two important oxygen-utilizing organelles in eukaryotic cells. Mitochondria carry out cellular respiration—the process that converts energy from food into ATP. Peroxisomes carry out a variety of functions, primarily breaking down different substances, such as fatty acids.The peroxisome is a single membrane-bound cellular organelle that can perform several different functions, including lipid metabolism and chemical detoxification. The enzymes within peroxisomes...
Drug Metabolism: Phase II Reactions01:14

Drug Metabolism: Phase II Reactions

Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
Drug Elimination: Non-Renal Routes01:23

Drug Elimination: Non-Renal Routes

The liver plays a pivotal role in eliminating drugs and their metabolites, primarily through a process known as biliary excretion. This process involves the hepatocytes, the primary cells in the liver that generate bile. A range of transporters actively expels polar drugs or hydrophilic drug metabolites into the bile, which transports the drugs and metabolites into the small intestine. From here, they are eventually expelled from the body through feces. In some instances, the original drug or a...
Enhanced Elimination of Poison01:26

Enhanced Elimination of Poison

Poison can be effectively removed from the gastrointestinal (GI) tract through various decontamination procedures.
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation01:22

Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation

Glutathione, a tripeptide made up of glutamate, cysteine, and glycine, is a critical player in the detoxification of drugs and xenobiotics via a process known as glutathione conjugation or mercapturic acid formation. This phase II biotransformation reaction involves the covalent binding of glutathione to a drug or its metabolite, enhancing the compound's water solubility and enabling its excretion.
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...